Početna › Veliki depresivni poremećaj › Washington
Kliničke studije za Veliki depresivni poremećaj u državi Washington
21 studija za Veliki depresivni poremećaj traži sudionike na lokacijama u državi Washington.
Gradovi u državi Washington
Službeni tekst studije (engleski)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Core Clinical Research, Everett
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Bellevue
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06830044A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07065240A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 26. kol 2026. · NCT07300969Positive Processes and Transition to Health (PATH)
- University of Washington, Seattle
U tijeku regrutacija
Od 18 do 65 godina · Oba spola · Ažurirano 19. kol 2026. · NCT06093906Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 14. kol 2026. · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Seattle Neuropsychiatric Treatment Center, Seattle
- VA Portland Healthcare System, Vancouver
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 6. kol 2026. · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT06966401A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center /ID# 277484, Bellevue
- Core Clinical Research /ID# 277518, Everett
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 15. lip 2026. · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 11. svi 2026. · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #143, Bellevue
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 20. sij 2026. · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. lis 2025. · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 23. sij 2025. · NCT06223880InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
- University of Washington Medical Center, Seattle
U tijeku regrutacija
Od 18 do 64 godina · Oba spola · Ažurirano 19. ruj 2024. · NCT06005194Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.